EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The levels of adropin and its therapeutic potential in diabetes

Marek Skrzypski, Tatiana Wojciechowicz iD, Agnieszka Rak iD, Małgorzata Krążek, Joanna Fiedorowicz, Mathias Z Strowski, Krzysztof W Nowak

Journal of Endocrinology · 31.01.2025 · 265 (1)

DOI: 10.1530/joe-24-0117 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Endocrinology, erschienen am 31.01.2025. Verfasst von Marek Skrzypski und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Intercellular Signaling Peptides and Proteins, Diabetes Mellitus, Peptides. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 120 Literaturangaben. Gefördert von: Narodowym Centrum Nauki.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adropin, a peptide hormone encoded by the energy homeostasis-associated gene, is expressed in various tissues, including the brain. Accumulating evidence from in vivo and in vitro studies highlights adropin's pivotal role in modulating carbohydrate and lipid metabolism. Notably, circulating adropin levels are lower in overweight and obese humans, and experimental interventions involving adropin overexpression or synthetic administration demonstrate promising outcomes in mitigating obesity-related metabolic abnormalities and preventing weight gain. This review comprehensively summarizes the current understanding of adropin's potential implications in diverse types of diabetes. Specifically, it explores adropin's utility as a biomarker for different types of diabetes and elucidates its significance as a potential predictor of diabetic adverse outcomes. Furthermore, the review delves into the beneficial effects of adropin treatment in animal models of experimentally induced diabetes, shedding light on its mechanisms of action in modulating glucose metabolism. In this comprehensive overview, we aim to provide a nuanced understanding of multifaceted role of adropin in diabetes pathogenesis and its therapeutic potential in combating this global health challenge.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intercellular Signaling Peptides and ProteinsDiabetes MellitusPeptidesHumansAnimalsBlood ProteinsBiomarkersObesity

Stichwörter der Autor:innen

GPR19adropindiabetesenergy homeostasis associated geneglucose

Substanzen

Enho protein, humanIntercellular Signaling Peptides and ProteinsBlood ProteinsBiomarkersPeptides

Autor:innen und Institutionen

ORCID-Profile: Tatiana Wojciechowicz, Agnieszka Rak

Förderung

  • Narodowym Centrum Nauki

Zitieren

APA

Skrzypski, M., Wojciechowicz, T., Rak, A., Krążek, M., Fiedorowicz, J., Strowski, M. Z., & Nowak, K. W. (2025). The levels of adropin and its therapeutic potential in diabetes. Journal of Endocrinology, 265(1). https://doi.org/10.1530/joe-24-0117

Vancouver

Skrzypski M, Wojciechowicz T, Rak A, Krążek M, Fiedorowicz J, Strowski MZ, et al. The levels of adropin and its therapeutic potential in diabetes. Journal of Endocrinology. 2025;265(1). doi:10.1530/joe-24-0117

BibTeX
@article{Skrzypski2025,
  author = {Skrzypski, Marek and Wojciechowicz, Tatiana and Rak, Agnieszka and Krążek, Małgorzata and Fiedorowicz, Joanna and Strowski, Mathias Z and Nowak, Krzysztof W},
  title = {The levels of adropin and its therapeutic potential in diabetes},
  journal = {Journal of Endocrinology},
  year = {2025},
  volume = {265},
  number = {1},
  doi = {10.1530/joe-24-0117}
}
Kostenlos starten →